Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Yingli He: Building a Defense Against Liver Cancer—Antiviral Treatment Strategies for CHB Patients in the Context of Comprehensive Liver Cancer

    Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) presents a significant public health challenge in China, with the majority of HCC patients being diagnosed at an advanced stage. Postoperative survival rates for HBV-related HCC patients are often poor. Therefore, the prevention and treatment of HBV-related HCC urgently require comprehensive management. China has achieved remarkable success in…

    2024.08.16
  • How Should Chinese Women Approach Breast Cancer Screening?

    Breast cancer has now become the most common malignant tumor worldwide and is one of the most prevalent cancers among Chinese women, posing a serious threat to their physical and mental health. While significant progress has been made in the treatment and drug development for breast cancer, providing more targeted treatment options for different types…

    2024.08.16
  • In-Depth Analysis | Dr. Yuhua Song & Dr. Jing Yao: Treatment Options for HR+/HER2- Breast Cancer Patients After CDK4/6i Progression

    After CDK4/6i treatment failure in HR+/HER2- breast cancer patients, do you lean more towards a PI3K inhibitor or an AKT inhibitor? At the Northern Salon of the 2024 Summer Breast Cancer Forum, during the “In-Depth Analysis” segment, Dr. Yuhua Song from The Affiliated Hospital of Qingdao University and Dr. Jing Yao from Union Hospital Affiliated…

    2024.08.16
  • In-Depth Analysis | Dr. Xuening Ji & Dr. Chunfang Hao: Treatment Options After TKI Therapy Failure in HER2-Positive Breast Cancer

    After the failure of TKI therapy in HER2-positive breast cancer, would you prefer an “ADC” or “HP+” regimen? At the Northern Salon of the 2024 Summer Breast Cancer Forum, during the “In-Depth Analysis” segment, Dr. Xuening Ji from Affiliated Zhongshan Hospital of Dalian University and Dr. Chunfang Hao from Tianjin Cancer Hospital shared their perspectives.…

    2024.08.16
  • Dr. Jidong Jia: Progress and Challenges in the Prevention and Treatment of Hepatitis B in China

    China has historically been a high-prevalence area for Hepatitis B virus (HBV) infection, with a hepatitis B surface antigen (HBsAg) prevalence rate of 9.7% in 1992. Comprehensive strategies, including the hepatitis B vaccine program for newborns (HepB), with a strong emphasis on timely administration of the birth dose and completion of the three-dose schedule, have…

    2024.08.15
  • Expert Commentary | Dr. Lin Zhang: Immune Activation as the Foundation for Sustained Efficacy of Yttrium-90 Radioembolization in Liver Cancer

    Yttrium-90 (Y90) resin microsphere selective internal radiotherapy (Y90-RE) is a minimally invasive local treatment method that can effectively control tumor progression in hepatocellular carcinoma (HCC) patients who are ineligible for resection or ablation, with compensated liver function and good overall condition. With the advancement of precision medicine, the clinical understanding of immune activation by Y90-RE…

    2024.08.15
  • SIFIC Insights: “The Essential Growth Path for Infection Control Professionals” & “Supporting the Future of China’s Infection Control Field”

    The 20th Shanghai International Forum for Infection Control (SIFIC), in conjunction with the 8th Oriental Forum on Challenging Infectious Diseases (OFCID) and the Academic Corference of Global Chinese Association of Clinical Microbiology & Infectious Diseases (SIFIC 2024 “National Infection Control and Challenging Infectious Diseases” Combined Conference), was grandly inaugurated in Shanghai. “Xiaoshi,” a reporter from…

    2024.08.15
  • Precision Diagnosis and Control: SIFIC’s milestone conference for 20 years opens, drawing a new blueprint for infection control

    On July 26, 2024, the highly anticipated 20th Shanghai International Forum for Infection Control (SIFIC), in conjunction with the 8th Oriental Forum on Complex Infectious Diseases (OFCID) and the Annual Meeting of the Global Chinese Society of Clinical Microbiology and Infectious Diseases, was grandly inaugurated at the Shanghai International Conference Center. Themed “Precision Diagnosis, Precision…

    2024.08.15
«previous next»
Recent Posts
  • Professor Hou Hsin-An: Deepening Cross-Strait Hematology Exchange and Exploring New Pathways for Precision Diagnosis and Treatment | 2026 Cross-Strait Hematology Conference
  • the 14th Lu Daopei Hematology Forum丨Dr. Chen Man: Immune Monitoring for Precise Differentiation — Clinical Applications of Lymphocyte Subset Analysis in Transplantation Complications
  • Professor Zhang Xiaohui Elected Vice Chair-Elect of the Hematology Branch of the Chinese Medical Association
  • the 14th Lu Daopei Hematology Forum丨Professor Robert Negrin: From Fundamental Research to Clinical Translation — Milestones in Regulatory T-Cell Research and Prospects for Clinical Applications
  • The 14th Ludaopei Hematology Academic Conference丨Professor Robert Negrin: From Fundamental Research to Clinical Translation — Milestones in Regulatory T-Cell Research and Prospects for Clinical Applications
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top